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Abstract: 
Background: Pseudomonas species are responsible for different healthcare-associated infections and are 
inherently resistant to many commonly used antibiotics. Hospital antibiograms are either absent or not 
regularly available in most healthcare facilities in Nigeria. The objective of this study is to present the 
antibiogram of Pseudomonas isolates in Federal Teaching Hospital Gombe (FTHG) in order to guide antibiotic 
prescription for better patient safety in the hospital.                              
Methodology: The is a hospital-based cross-sectional study. A total of 4309 bacterial isolates were recovered 
from aerobic cultures of routine clinical specimens including urine, sputum, blood, swabs, aspirates, biopsies, 
seminal fluids and cerebrospinal fluids at the Medical Microbiology laboratory of the hospital between January 
and December 2019. Pseudomonas species were identified by colony morphology, Gram-reaction and 
conventional biochemical tests. Antibiotic susceptibility testing was performed on each Pseudomonas isolate 
using the modified Kirby-Bauer disk diffusion method on Mueller-Hinton agar and results interpreted according 
to the guideline of the Clinical and Laboratory Standards Institute (CLSI). Data were analysed using the 
Statistical Package for Social Sciences (SPSSTM) software version 23.0.                             
Results: Of the total 4309 bacterial isolates, 436 (10.1%) Pseudomonas species were identified, with majority 
(49.8%) from urine specimens. Antibiotic susceptibility test results revealed average susceptibility rates of 
73.8%, 70.1%, 66.2%, 59.5%, and 34.3% to ciprofloxacin, gentamicin, levofloxacin ceftazidime, and 
carbenicillin respectively. These rates fluctuate only slightly for each of the antibiotic during the 12 months 
period of survey.                                          
Conclusion: Pseudomonas species were most sensitive to ciprofloxacin and gentamicin among the first line 
antibiotics in FTHG in 2019. Regular updates and presentation of hospital antibiogram especially for intrinsically 
resistant bacteria such as Pseudomonas involved in healthcare associated infections, is an important tool in 
combating antimicrobial resistance and ensuring patient safety.  
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Abstrait: 
Contexte: Les espèces de Pseudomonas sont responsables de différentes infections associées aux soins de 
santé et sont intrinsèquement résistantes à de nombreux antibiotiques couramment utilisés. Les 
antibiogrammes hospitaliers sont absents ou ne sont pas régulièrement disponibles dans la plupart des 
établissements de santé au Nigéria. L'objectif de cette étude est de présenter l'antibiogramme des isolats de 
Pseudomonas dans l'Hôpital Universitaire Fédéral de Gombe (FTHG) afin d'orienter la prescription 
d'antibiotiques pour une meilleure sécurité des patients à l'hôpital.                              
Méthodologie: Il s'agit d'une étude transversale en milieu hospitalier. Un total de 4309 isolats bactériens ont 
été récupérés à partir de cultures aérobies d'échantillons cliniques de routine, y compris l'urine, les crachats, le 
sang, les prélèvements, les aspirations, les biopsies, les fluides séminal et les fluides céphalo-rachidiens au 
laboratoire de microbiologie médicale de l'hôpital entre janvier et décembre 2019. Les espèces de Pseudomonas 
étaient identifié par la morphologie de la colonie, la réaction Gram et les tests biochimiques conventionnels. 
Des tests de sensibilité aux antibiotiques ont été réalisés sur chaque isolat de Pseudomonas en utilisant la 
méthode de diffusion sur disque Kirby-Bauer modifiée sur gélose Mueller-Hinton et les résultats ont été 
interprétés selon les directives du Clinical and Laboratory Standards Institute (CLSI). Les données ont été 
analysées à l'aide du logiciel Statistical Package for Social Sciences (SPSSTM) version 23.0.                  
Résultats: Sur les 4309 isolats bactériens au total, 436 (10,1%) espèces de Pseudomonas ont été identifiées, 
la majorité (49,8%) à partir d'échantillons d'urine. Les résultats des tests de sensibilité aux antibiotiques ont 
révélé des taux moyens de sensibilité respectivement de 73,8%, 70,1%, 66,2%, 59,5% et 34,3% à la 
ciprofloxacine, à la gentamicine, à la lévofloxacine ceftazidime et à la carbénicilline. Ces taux ne fluctuent que 
légèrement pour chacun des antibiotiques au cours de la période de 12 mois d'enquête.                 
Conclusion: les espèces de Pseudomonas étaient les plus sensibles à la ciprofloxacine et à la gentamicine 
parmi les antibiotiques de première intention dans le FTHG en 2019. Les mises à jour régulières et la 
présentation de l'antibiogramme hospitalier, en particulier pour les bactéries intrinsèquement résistantes telles 
que les Pseudomonas impliquées dans les infections associées aux soins, sont un outil important dans la lutte 
contre la résistance aux antimicrobiens et assurer la sécurité des patients. 
Mots clés: antibiogramme, Pseudomonas, résistance aux antimicrobiens, gestion des antimicrobiens, sécurité 
des patients 
Introduction:      
 Antibiogram is a summary of the 
periodic susceptibility pattern of organisms 
isolated within a specific area which is regu- 
larly communicated to the hospital com- 
munity to guide appropriate use of anti- 
microbials and empirical treatment of infec- 
tions (6), while patient safety is a health care 
discipline that focuses more on preventing, 
controlling, and minimizing risks, harm, and 
errors in healthcare (7). Patient safety toge- 
ther with antimicrobial stewardship and 
infection prevention and control (IPC) consti- 
tutes the major pillars of an integrated 
approach to health systems strengthening 
(7).      
 Inappropriate use of antimicrobials is 
the main driving force in the development of 
resistance by microorganisms, and these 
resistant organisms pose significant threat to 
patient safety globally (8). Antibiogram clas- 
sically promote optimal use of antimicrobials 
by encouraging a targeted approach,thereby 
reducing treatment-related cost and also 
minimizing or slowing the development of 
antimicrobial resistance leading to improved 
quality of life and patient safety (7). 
 
 Pseudomonas are non-fermentative 
oxidase-positive, motile, aerobic Gram-nega- 
tive rods belonging to the family Pseudomo- 
nadaceae, with a large genome of approxi- 
mately  6.3 million base pairs (Mbp), enco- 
ding 5567 genes(1). Pseudomonas commonly 
colonizes hospital environment, equipment, 
and have remained a prominent cause of 
healthcare-associated infections (HAIs) (2). 
They typically cause diseases in immuno- 
compromised individuals but occasionally 
infects immunocompetent hosts, and are 
often associated with ventilator-associated 
pneumonia (VAP), central line-associated 
bloodstream infection (CLABSI), surgical site 
infection (SSI), respiratory infections in cystic 
fibrosis (CF) patients, and catheter-asso- 
ciated urinary tract infections (CAUTI) (3,4).
 Pseudomonas generally possesses 
several virulence factors including lipopoly- 
saccharide, type IV pili, type III and VI secre- 
tion systems, alginate,  exotoxin A, pro- 
teases, quorum sensing,  generation of oxi- 
dants in the airways, formation of biofilm and 
pigments (1). Pseudomonas generally are 
intrinsically resistant to several antibiotics, 
and recently, more resistance from acquired 
sources is progressively increasing (5). 
 Studies specifically on Pseudomonas 
antibiogram are few in this part of the 
country. Communication and dissemination of 




antiogram outcomes to health care workers, 
hospital community, and globally on regular 
basis, is also lacking. In this study, we 
present the FTHG 2019 Pseudomonas anti- 
biogram, which is aimed at providing a guide 
for the empirical antibiotic prescribing prac- 
tices among physicians to combat antimicro- 
bial resistance for better patient safety. 
 The average sensitivity rates of Pseu- 
domonas species against commonly used 
antibiotics in our facility were 73.8% (cipro- 
floxacin), 70.1% (gentamicin), 66.2% (levo- 
floxacin), 59.5% (ceftazidime) and 34% (car- 
benicillin) (Fig 1).  
 
Table 1: Distribution of Pseudomonas species 
isolated from different clinical specimens 
 
Materials and method: 
 
Specimen type No of Pseudomonas (%) Study setting and ethical approval 
 This is a hospital-based cross-sec- 
tional study carried out in FTHG, a 457 beded  
tertiary hospital in north-eastern Nigeria. The 
hospital has a functional IPC programme and 
multidisciplinary patient safety team (MPST). 
Ethical approval for this study was obtained 
from the research and ethics committee of 
FTHG. 




Sputum 53 (12.1) 
Blood 20 (4.6) 




Identification and antibiotic susceptibility of 
Pseudomonas specie isolates  
 All Pseudomonas isolates recovered 
from clinical specimens (urine, sputum, 
blood, swabs, aspirates, biopsies, and semi- 
nal fluids) received and processed from at the 
Medical Microbiology laboratory of FTHG from 
January to December 2019, were included. 
Identification of Pseudomonas species was 
manually done using conventional methods 
including colonial morphology, Gram stain 
reaction, oxidase and motility tests.  
 Invitro susceptibility testing of the 
isolates to five commonest first-line anti-
Pseudomonas antibiotics in our facility was 
performed by the modified Kirby-Bauer disk 
diffusion method on Mueller-Hinton agar 
using single antibiotic disks (ceftazidime 
30µg, gentamicin 10µg, ciprofloxacin 5µg, 
levofloxacin 5µg and carbenicillin 100µg) 
(Oxoid, UK). The zone diameter of inhibition 
(measured in millimetres) for each isolate 
was interpreted as sensitive or resistant 
using the guidelines of the Clinical and 
Laboratory Standards Institute (CLSI) for 
Pseudomonas (9).  
 Pseudomonas species are organisms 
with a remarkable propensity to develop 
resistance to a wide range of antibiotics more 
commonly in hospital settings. It has inhe- 
rent resistance to many commonly used anti- 
biotics thereby making it a frequent agent 
responsible for inappropriate empirical anti- 
biotic therapy which is associated with inc- 
reased healthcare burden. Poor prescribing 
practices have been identified as a major 
driver in the development of resistance 
against antibiotics with Pseudomonas being 
very prominent.   
 This study revealed a relatively high 
prevalence of Pseudomonas (10.1%) among 
other bacterial isolates recovered from 
clinical specimens in Gombe, which is similar 
to 9.7% reported by Dash et al.,(10) in 
Peshawar, but higher than 5.1% reported in 
Nepal (11). This further highlights the signi- 
ficance of this pathogen and the importance 
of having an antibiogram to guide empiric 
antibiotic prescription especially given its 
inherent resistance to many commonly used 
drugs in the treatment of bacterial infections. 
 About half of the isolated Pseudo- 
monas were from urine specimen which 
conforms to the findings by Shrestha et al., 
(11) and probably because urine is also the 
most common specimen received in our 
laboratory during the period Miscellaneous 
specimens such as swabs and aspirates 
usually from skin and soft tissue infections 
(SSTIs) and surgical site infection (SSIs) 
were very common sources of Pseudomonas 
isolates in our study, and similar to the 
findings of Dash et al., (12) in South Odisha, 
India.     
 The invitro susceptibility of Pseudo- 
monas to ciprofloxacin was high at 73.8% 
average in this study, which was a similar 
 
Data analysis    
 Data were analysed using the Stati- 
stical Package for Social Sciences (SPSSTM) 
software version 23.0. 
 
Results: 
 Of the total 4309 bacterial isolates 
recovered from clinical specimens in 2019 at 
the Medical Microbiology laboratory of FTHG, 
Pseudomonas species were 436 (10.1%), 
about half (49.8%) of which were isolated 
from urine specimens while others were as 
shown in Table 1. The monthly distribution 
and percentage antibiotic susceptibility of the 
Pseudomonas species are highlighted in Table 
2.  




Table 2: Monthly distribution of Pseudomonas species recovered from clinical specimens and their antibiotic 










LEV CAZ CN CAR 
January 49 (11.2)  33 (67.3) 28 (57.1) 31 (63.3) 32 (65.3) 9 (18.4) 
February 24 (5.5) 16 (66.7) 14 (58.3) 14 (58.3) 16 (66.7) 12 (50.0) 
March 35 (8.0) 28 (80.0) 21 (60.0) 21 (60.0) 23 (65.7) 15 (42.9) 
April 37 (8.5) 30 (81.1) 22 (59.5) 22 (59.5) 26 (70.3) 13 (35.1) 
May 19 (4.4) 13 (68.4) 12 (63.2) 13 (68.4) 14 (73.7) 5 (26.3) 
June 40 (9.2) 28 (70.0) 29 (72.5) 28 (70.0) 30 (75.0) 16 (40.0) 
July 29 (6.7) 20 (69.1) 19 (65.5) 17 (58.6) 22 (75.9) 17 (58.6) 
August 40 (9.2) 30 (75.0) 32 (80.0) 25 (62.5) 26 (65.0) 17 (42.5) 
September 47 (10.8) 37 (78.7) 32 (68.1) 28 (59.6) 37 (78.7) 13 (27.7) 
October 42 (9.6) 35 (83.3) 32 (72.2) 21 (50.0) 28 (66.7) 9 (21.4) 
November 51 (11.7) 36 (70.6) 40 (78.2) 27 (52.9) 34 (66.7) 13 (25.5) 
December 23 (5.2) 18 (78.3) 14 (61.0) 12 (52.2) 18 (78.3) 11 (49.0) 









CIP = Ciprofloxacin, LEV = Levofloxacin, CAZ = Ceftazidime, CN = Gentamicin, CAR = Carbenicilin 
 
 
Fig 1: Average percentage sensitivity and resistance of Pseudomonas to first-line antimicrobials 
pattern reported by Balogun et al., (13) in 
Maiduguri, which is in the same geographical 
region as Gombe in Nigeria. Geographical and 
social similarity, as well as prescribing habits 
and health indices between Gombe and 
Maiduguri, could play a role in this context. 
The susceptibility to gentamicin was also 
relatively high, similar to that reported by 
Shrestha et al.,(11). The 59.6% susceptibility 
rate to ceftazidime (a third generation cepha- 
losporin) reported in this study is similar to 
the rate reported by Gill et al., (14) and 
Iregbu et al., (15). A study in Saudi-Arabia 
by Rashid et al., (16) reported 70.0% sensi- 
tivity of Pseudomonas to levofloxacin, which 
is similar to 66.2% reported by us, as against 
a higher resistance rate  36.1% reported by 
Dash et al.(12).  
 Carbenicillin, a carboxypenicillin used 
in the treatment of Pseudomonas infections, 
showed little invitro efficacy as only 34.3% of 






















in our study, similar to a  study conducted by 
Jazani et al., in Iran with 35% sensitivity 
rate. This high resistance rate may be due to 
the increasing transfer of beta-lactamase 
genes between Pseudomonas species and 
members of the family Enterobacteriaceae 
(17).     
 The monthly susceptibility rates show 
very little variations of Pseudomonas isolates 
to each of the 5 commonly used anti-Pseudo- 
monas antibiotics in our facility. These anti- 
biogram results were discussed monthly and 
annually presented to the hospital community 
at the instance of the MPST, outlining the 
trend of infection, susceptibility, and resistant 
patterns of Pseudomonas species to guide 
and improve antibiotic prescribing practices.  
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Conclusion:  
 Antibiogram remains an important 
tool in combating AMR through improved 
prescribing practices at all levels of health- 
care delivery. Pseudomonas are among the 
common clinically important bacterial isolates 
in Gombe and most commonly recovered 
from urine and swabs/aspirates associated 
with healthcare-associated urinary tract and 
skin/soft tissue infections. Among the first 
line antibiotics at FTHG in 2019, Pseudo- 
monas were most sensitive to ciprofloxacin 
and least sensitive to carbenicillin.  
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